Get it on Google Play

Spectranetics (SPNC) Announces CE Mark Approval for ThromCatXT

June 23, 2009 7:05 AM EDT Send to a Friend
Spectranetics Corporation (Nasdaq: SPNC) received the CE mark approval for its next-generation ThromCat XT Thrombus ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login